The following is a letter sent today from our office to the Irish Medicines Board today seeking a copy of a report drafted by Covance Laboratories of Harrogate, North Yorkshire analysing the composition of faulty PIP breast implants.
Our Ref: EMcG Your Ref; 21st May 2012
The Chief Executive
Irish Medicines Board
Kevin O’Malley House,
Fax: 676 7836
Re: PIP Breast Implants
We write this as an open letter to you and will put it on our website.
We are instructed by a number of women that have been fitted with defective breast implants manufactured by Poly Implant Prothèses (PIP) and in connection with their claims for personal injuries arising therefrom.
We understand that Covance Laboratories of Harrogate, North Yorkshire have completed a report into the constituent parts of the PIP breast implants. This is recorded in a newspaper report of the UK “Daily Star” of 13th May 2012. The report quotes a spokesman for the UK Medicines and Healthcare Products Regulatory Agency as saying that the report is published on the website of the Agency.
We have been unable to locate the report on that website and would be obliged if you would use your good offices with the Medicines and Healthcare Products Regulatory Agency to get a copy for us. Publishing it on your website or providing a web link would be very acceptable.
We await hearing from you in due course.